➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Dow
Baxter
Mallinckrodt
Merck

Last Updated: June 4, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Silver nitrate


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Silver nitrate?

Silver nitrate is an investigational drug.

There have been 19 clinical trials for Silver nitrate. The most recent clinical trial was a Phase 3 trial, which was initiated on April 1st 2019.

The most common disease conditions in clinical trials are Granuloma, Pleural Effusion, Malignant, and Pleural Effusion. The leading clinical trial sponsors are Assiut University, The University of Hong Kong, and University of Saskatchewan.

There are seventy-nine US patents protecting this investigational drug and five hundred and ninety-two international patents.

Recent Clinical Trials for Silver nitrate
TitleSponsorPhase
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital WartsAssiut UniversityPhase 3
A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in ChildrenDalhousie UniversityPhase 4
A Prospective Evaluation of Non-Operative Treatments for Gastrocutaneous Fistulae in ChildrenMontreal Children's Hospital of the MUHCPhase 4

See all Silver nitrate clinical trials

Clinical Trial Summary for Silver nitrate

Top disease conditions for Silver nitrate
Top clinical trial sponsors for Silver nitrate

See all Silver nitrate clinical trials

US Patents for Silver nitrate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent, polymerizable compound and a fluorine atom-containing compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Light-sensitive material containing silver halide, reducing agent and polymerizable compound Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Image forming method using microcapsules containing silver halide and a salt of a reducing agent Fuji Photo Film Co., Ltd. (Kanagawa, JP)   Start Trial
Silver nitrate   Start Trial Substituted aminomethanediphosphonic acids and use in medicaments Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
Silver nitrate   Start Trial Seed layer compositions containing organogold and organosilver compounds   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Silver nitrate

Drugname Country Document Number Estimated Expiration Related US Patent
Silver nitrate Japan H0282247 2008-09-19   Start Trial
Silver nitrate Germany 3783474 2006-02-07   Start Trial
Silver nitrate European Patent Office 0232865 2006-02-07   Start Trial
Silver nitrate Japan H0619570 2006-02-07   Start Trial
Silver nitrate Japan S62183453 2006-02-07   Start Trial
Silver nitrate Japan H0623837 2006-10-17   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Moodys
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.